Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-108 in Chronic Schizophrenia
NCT00505765Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2007
- Primary completion
- Apr 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of davunetide in schizophrenia, sponsored by University of California, Los Angeles. Started Jul 2007; status: completed.
02
Drugs
davunetide
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00505765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505765.